A1LN34 / Alnylam Pharmaceuticals, Inc. - Depositary Receipt (Common Stock) - Ai+ Enhanced Message Board

Alnylam Pharmaceuticals, Inc. - Depositary Receipt (Common Stock)

BR ˙ BOVESPA

78,41 R$ ↑5,89 (8,12%)

2026-06-05
AKTIENPREIS

Share Your Thoughts or Ask a Question

Titel Text Sagen Sie uns, was Sie zu sagen haben. Sie können Links einfügen, aber nicht *nur* Links. Teilen Sie uns Ihre Meinung mit. Verwenden Sie Markdown .

Using Standard

Subscribe for smarter answers and premium data.

How Much do you Like Fintel?

Please share your opinion of our service!

5

4

3

2

1

Excellent Bad

Fintel data has been cited in the following publications:

© 2015-2026 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.